CEA can detect the recurrence of colorectal cancer with high evidence of clinical utility, and also help determine the response or progression in metastatic breast cancer.[4] CEA test is considered non-invasive as it can be detected in blood samples. Here, CEACAM5 is linked to colorectal cancer.